Walgreens to acquire 45 per cent stake in Alliance Boots in £4.27bn deal

Breaking news US pharmacy chain Walgreens has entered into a £4.27 billion cash and stock deal to acquire a 45 per cent stake in health and beauty giant...
Forgotten your password?
The page you are looking for is only available to logged in members of Chemist+Druggist.
Not a member yet?
Register now
If you are not a registered user, then please sign up here. Registering is free and takes just seconds. It gives you access to up-to-the minute news alerts and analysis, all our top bloggers.
If you experience any difficulties logging in or registering, or have any other questions, please contact Chemist+Druggist at haveyoursay@chemistanddruggist.co.uk
Comment on this article
You are not currently logged in. Login or register
Your Comments
Brian Austen, Non healthcare professional
Posted on 19 June 2012.
This seems to be a discounted price. Is this Mr Pessina implementing an exit strategy. I would still worry about my job if I was part of the Boots senior or middle management, esspecially once Wagreens become the majority owners. We have heard promises before in other industries, Cadbury's for example where all promises were quickly forgotten once the old regime were no longer in charge.
Top
Brian Austen, Non healthcare professional
Posted on 19 June 2012.
I wonder how the under funded pension fund will be affected by this deal. Maybe that is the reason for the discounted price.
Top
Rajive Patel, Community pharmacist
Posted on 19/06/12 16:02 in reply to Brian Austen.
I think this is more of a deal to keep KKR happy. Its been 5 years since their acquisition and normally PE (Private Equity) dont keep holdings for much longer than this. Infact KKR will get back the cash aspect of what they invested thereby allowing them to return monies to their backers. They put in £1.2B and will get back £1.2B in 95% cash and rest as wallgreen stock.

Pessina on the other hand will not take a majority of cash and will remain well invested in the new entity. It definitely looks like Wallgreens will buy out the whole venture in 2 and half years, for the pre-defined $9.3Billion. At this price and assuming net debts KKR and Pessina will have returned 2.2 x their initial investment in 7 years - this is not bad considering you are talking billions.

Anyway, it seems like a well constructed deal and I applaud Pessina's driving vision to create a true global retail pharmacy giant. I suspect when KKR eventually exit, Pessina will be there in the driving seat maintaining a large portion of Equity in the new enlarged Boots/Wallgreen. Pessina is a credit to British enterprise and for British Manufacturing, because Nottingham will be the real beneficiary with new jobs created to allow the increased output to market Boots Brands (e.g. No 7) into the US.

WELL DONE MR PESSINA!!!!
Top
Clive Hodgson, Community pharmacist
Posted on 19/06/12 17:08 in reply to Brian Austen.
May not be good news for Boots pharmacy employees. Google "Walgreens phamacist layoffs" or similar. They do not seem to have the greatest of relations with their pharmacists.
Top
Stephen Walsh, Community pharmacist
Posted on 19/06/12 18:44 in reply to Clive Hodgson.
That much they have in common with Boots then.
Top
Chris Locum, Locum pharmacist
Posted on 20/06/12 06:18 in reply to Stephen Walsh.
A match made in corporate heaven.

Cut rates of pay. Terminate contracts. Ride rough shod over employees including pharmacists as well now.

A warning sign of a big business wanting to look attractive to an outside buyer - oh look what we have here...a buyer...
Top
Chris Locum, Locum pharmacist
Posted on 20/06/12 06:39 in reply to Rajive Patel.
I don't think anyone here could care less if KKR is 'happy'.

They will be pushing for remote supervision and layoffs or any way to reduce expenditure such as paying taxes elsewhere - and then... they will be 'happy' .
Top
Rajive Patel, Community pharmacist
Posted on 20/06/12 08:45 in reply to Chris Locum.
My comments were purely from a financial deal point of you. I am an independent contractor, but this does not mean I, by default, hate anything "positive" for our industry. Boots are a big player in the market and certainly the deal with Walgreens should be seen in a positive light, since this gives even better heavy weight representation when we go back to NHS Employers to negotiate a new contract.

The Americans are brash lot, but to their credit, they don't sit back and take things lying down.

As for a lot of disgruntled employee pharmacists, well this is the way forward in the new NHS, we all have to live with expectations of little or no growth in income due to our paymaster tightening his belt. It seems there is a complete disconnect between employee wage expectations and the real economy.

As for KKR, they have done a brilliant deal!! To make £1.5billion is a nice reward for a risky corporate takeover.
Top
Michael Major, Non healthcare professional
Posted on 20 June 2012.
Or maybe by liquidating their investment, KKR et al are buying into Vodafone's view that "Bricks-and-mortar healthcare facilities, including community pharmacies, will serve only as a last resort by 2020" (C&D article 11th June)
Top
Brian Austen, Non healthcare professional
Posted on 20 June 2012.
This is being made out to be a good business deal but the original purchase price paid in total was £12.4 Bn. This sale of 45% for £4.27 Bn values the whole business at £9.49 Bn.
There is more cash and less debt involved this time, which in the short-term will make the venture capitalists happy but it has not been a good investment. Boots pay very little corporation tax if any due to headquarters being based in Switzerland, just as Lloyds parent company in Germany. Independents cannot do such things. Walgreens will be looking for efficiencies to increase the return on their investment so as I said before, watch out Boots employees.
Top
Adina Brown, Community pharmacist
Posted on 20/06/12 20:51 in reply to Clive Hodgson.
birds of the same feather flock together.they sing from the same hymn book when it comes to relationships with the pharmcist who make them billionnaires
Top

Please note You must be a registered user of Chemist+Druggist and logged in to add comments. Opinions expressed here are those of the writers and do not necessarily reflect those of Chemist+Druggist. Comments are considered in the public domain and may be used in future Chemist+Druggist coverage. We accept no responsibility, legal or otherwise, for the accuracy or the content of member comments. However, any comments deemed to be libellous will be removed

Job of the week

Commercial Services Manager

Runcorn, Cheshire
£competitive

Follow C+D Jobs on

 
Should pharmacists be involved in the MMR catch-up programme?